Open AccessScientific report: a case of acute pancreatitis due to liraglutide
Author(s) -
Noé Quesada-Vázquez
Publication year - 2018
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2018.5912/2018
Subject(s) - liraglutide , medicine , acute pancreatitis , pancreatitis , epigastric pain , complication , diabetes mellitus , general surgery , type 2 diabetes , emergency department , gastroenterology , intensive care medicine , endocrinology , vomiting , psychiatry
Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) analog. GLP-1 analogues are used as a second option treatment for type 2 diabetes and weight management in obese patients. Data in the literature suggests an association between GLP-1 agonist use and acute pancreatitis (AP). Furthermore, it has been suggested that acute pancreatitis is a potential complication of liraglutide therapy and liraglutide should be used cautiously in patients at risk of pancreatitis. This case reported herein was a 44-year-old female diagnosed with acute pancreatitis based on 2 of 3 criteria when she presented to the Emergency Department with epigastric pain, which radiated to her back.